43742-2033 NDC - ECHINACEA (ANGUSTIFOLIA), HYDRASTIS CANADENSIS, NASTURTIUM AQUATICUM, THUJA OCCIDENTALIS, THYMUS (SUIS), EUPATORIUM PERFOLIATUM, GELSEMIUM SEMPERVIRENS, IODIUM, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, SELENIUM METALLICUM, ZINCUM METALLICUM, HERPES SIMPLEX I AND II NOSODE, HERPES ZOSTER NOSODE, POLIOMYELITIS NOSODE, EPSTEIN BARR VIRUS NOSODE, CYTOMEGALOVIRUS NOSODE, MORBILLINUM, PAROTIDINUM, RUBELLA NOSODE, PYROGENIUM, HEPATITIS B NOSODE, COXSACKIE B1 NOSODE,

Drug Information

  • Product NDC: 43742-2033
  • Proprietary Name:
  • Non Proprietary Name: Echinacea (Angustifolia), Hydrastis Canadensis, Nasturtium Aquaticum, Thuja Occidentalis, Thymus (Suis), Eupatorium Perfoliatum, Gelsemium Sempervirens, Iodium, Lachesis Mutus, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Selenium Metallicum, Zincum Metallicum, Herpes Simplex I and II Nosode, Herpes Zoster Nosode, Poliomyelitis Nosode, Epstein Barr Virus Nosode, Cytomegalovirus Nosode, Morbillinum, Parotidinum, Rubella Nosode, Pyrogenium, Hepatitis B Nosode, Coxsackie B1 Nosode,
  • Active Ingredient(s): 30 [hp_C]/mL ANTIMONY TRISULFIDE; 6 [hp_X]/mL ECHINACEA ANGUSTIFOLIA; 12 [hp_X]/mL EUPATORIUM PERFOLIATUM FLOWERING TOP; 12 [hp_X]/mL GELSEMIUM SEMPERVIRENS ROOT; 6 [hp_X]/mL GOLDENSEAL; 33 [hp_X]/mL HEPATITIS B VIRUS; 11 [hp_C]/mL HUMAN COXSACKIEVIRUS B1; 18 [hp_C]/mL HUMAN COXSACKIEVIRUS B4; 15 [hp_X]/mL HUMAN HERPESVIRUS 1; 15 [hp_X]/mL HUMAN HERPESVIRUS 2; 15 [hp_X]/mL HUMAN HERPESVIRUS 3; 18 [hp_C]/mL HUMAN HERPESVIRUS 4; 20 [hp_X]/mL HUMAN HERPESVIRUS 5; 12 [hp_X]/mL IODINE; 12 [hp_X]/mL LACHESIS MUTA VENOM; 30 [hp_C]/mL LEDUM PALUSTRE TWIG; 12 [hp_X]/mL LYCOPODIUM CLAVATUM SPORE; 30 [hp_X]/mL MEASLES VIRUS; 30 [hp_X]/mL MUMPS VIRUS; 6 [hp_X]/mL NASTURTIUM OFFICINALE; 12 [hp_X]/mL PHOSPHORIC ACID; 12 [hp_X]/mL PHOSPHORUS; 15 [hp_C]/mL POLIOVIRUS; 30 [hp_X]/mL RANCID BEEF; 30 [hp_X]/mL RUBELLA VIRUS; 12 [hp_X]/mL SELENIUM; 12 [hp_X]/mL STRYCHNOS NUX-VOMICA SEED; 8 [hp_X]/mL SUS SCROFA THYMUS; 30 [hp_C]/mL THIMEROSAL; 6 [hp_X]/mL THUJA OCCIDENTALIS LEAFY TWIG; 12 [hp_X]/mL ZINC
  • Administration Route(s):
  • Dosage Form(s): LIQUID

Labeler Information

Field Name Field Value
Labeler Name: Deseret Biologicals, Inc.
Product Type: DRUG FOR FURTHER PROCESSING
FDA Application Number:
Marketing Category: DRUG FOR FURTHER PROCESSING
Start Marketing Date:10/8/2020
End Marketing Date:2/1/2026

Package Information

No. Package Code Package Description Billing Unit
143742-2033-1960 mL in 1 BOTTLE, PLASTIC (43742-2033-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-2033The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEDRUG FOR FURTHER PROCESSINGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAMEEchinacea (Angustifolia), Hydrastis Canadensis, Nasturtium Aquaticum, Thuja Occidentalis, Thymus (Suis), Eupatorium Perfoliatum, Gelsemium Sempervirens, Iodium, Lachesis Mutus, Lycopodium Clavatum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Selenium Metallicum, Zincum Metallicum, Herpes Simplex I and II Nosode, Herpes Zoster Nosode, Poliomyelitis Nosode, Epstein Barr Virus Nosode, Cytomegalovirus Nosode, Morbillinum, Parotidinum, Rubella Nosode, Pyrogenium, Hepatitis B Nosode, Coxsackie B1 Nosode,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
START MARKETING DATE10/8/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE2/1/2026This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEDRUG FOR FURTHER PROCESSINGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEANTIMONY TRISULFIDE; ECHINACEA ANGUSTIFOLIA; EUPATORIUM PERFOLIATUM FLOWERING TOP; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HEPATITIS B VIRUS; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; IODINE; LACHESIS MUTA VENOM; LEDUM PALUSTRE TWIG; LYCOPODIUM CLAVATUM SPORE; MEASLES VIRUS; MUMPS VIRUS; NASTURTIUM OFFICINALE; PHOSPHORIC ACID; PHOSPHORUS; POLIOVIRUS; RANCID BEEF; RUBELLA VIRUS; SELENIUM; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA THYMUS; THIMEROSAL; THUJA OCCIDENTALIS LEAFY TWIG; ZINCAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30; 6; 12; 12; 6; 33; 11; 18; 15; 15; 15; 18; 20; 12; 12; 30; 12; 30; 30; 6; 12; 12; 15; 30; 30; 12; 12; 8; 30; 6; 12 
ACTIVE INGRED UNIT[hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025

Previous Code
Next Code